Skip to content

Post-Operative Trigeminal Pain After Microvascular Decompression for Trigeminal Neuralgia

Post-Operative Trigeminal Pain After Microvascular Decompression for Trigeminal Neuralgia

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07216547
Enrollment
100
Registered
2025-10-14
Start date
2025-12-12
Completion date
2026-06-01
Last updated
2025-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Microvascular Decompression Surgery, Post-operative Pain, Trigeminal Neuralgia

Keywords

post operative relapse

Brief summary

The goal of this observational study is to learn about the long-term effects of microvascular decompression (MVD) in patients with trigeminal neuralgia (TN). The main question it aims to answer is: Does undergoing post-operative dental treatment or other orofacial stimulation increase the likelihood of pain relapse after MVD for TN? Participants who have previously undergone MVD for TN as part of their standard medical care will be asked to complete surveys over phone call. These surveys will focus on their pain experiences, timing, anxiety attacks and nature of any pain relapses, and whether they have received dental treatments or other orofacial interventions during follow-up.

Interventions

None listed

Sponsors

Rutgers, The State University of New Jersey
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* MVD post-operative patients with type I Trigeminal Neuralgia.

Exclusion criteria

* Atypical (Type II) Facial Pain at presentation, revision surgery. * Patients who are unable or unwilling to provide informed consent will be excluded from the study.

Design outcomes

Primary

MeasureTime frameDescription
Pain control following microvascular decompression (MVD)Up to 60 months post-surgeryPain control will be assessed using the Barrow Neurological Institute (BNI) Pain Scale to evaluate changes in pain severity and relief after MVD.

Countries

United States

Contacts

Primary ContactSowmya Akkineni, BDS
sowmyaakkineni19@gmail.com540-408-7645
Backup ContactSowmya Ananthan, BDS, DMD, MSD
ananths1@sdm.rutgers.edu732-322-8182

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026